Infection in Solid Organ Transplant Recipients clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
The T-SPOT assay quantifies the number of peripheral blood interferon-γ producing effector T cells [spot forming cells/million peripheral blood mononuclear cells - PBMC)]. The T-SPOT platform technology can be applied to diagnose and monitor any major disease process driven by a T cell response, including a viral disease such as cytomegalovirus (CMV) infection (the T-SPOT.CMV assay) or an allograft rejection (the T-SPOT.PRT assay).
San Francisco, California and other locations